Year 2021 / Volume 113 / Number 2
Letter
Hepatitis C and beta-thalassemia major in children: experience with glecaprevir/pibrentasvir

150-151

DOI: 10.17235/reed.2020.7092/2020

Diannet Quintero García, Francisco José Sebastián Cuevas, Elena Crehuá Gaudiza,

Abstract
Hepatitis C virus (HCV) is estimated to affect 3.26 million children worldwide, with the highest number of cases registered in Pakistan and China. Vertical transmission is the principal route in industrialized countries. However, iatrogenic transmission is relevant in low-income settings. We present the case of a 12-year-old Pakistani child who suffered from beta-thalassemia major and hepatitis C, successfully treated with glecaprevir/pibrentasvir.
Share Button
New comment
Comments
No comments for this article
References
1. Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017;2(3):161-176.
2. Kamal S, Abdelhakam S, Ghoraba D, et al. The Course of Hepatitis C Infection and Response to Anti-viral Therapy in Patients with Thalassemia major and Hepatitis C Infection: A Longitudinal, Prospective Study. Mediterr J Hematol Infect Dis 2019;11(1):e2019060.
3. Indolfi G, Easterbrook P, Dusheiko G, et al. Hepatitis C virus infection in children and adolescents. Lancet Gastroenterol Hepatol 2019;4(6):477-487.
4. Wyles D, Poordad F, Wang S, et al. Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: a partially randomized phase 3 clinical trial: viral hepatitis. Hepatology 2018;67(2):514-523.
5. Jonas MM, Squires RH, Rhee S, et al. Pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir in adolescents with chronic hepatitis C virus: part 1 of the DORA study. Hepatology 2020;71(2):456-462.
6. Crespo J, Albillos A, Buti M, et al. Eliminación de la hepatitis C. Documento de posicionamiento de la Asociación Española para el Estudio del Hígado (AEEH). Rev Esp Enferm Dig 2019; 111(11):862-873. DOI: 10.17235/reed.2019.6700/2019
Related articles

Editorial

Treatment of portal vein thrombosis in cirrhosis patients

DOI: 10.17235/reed.2023.9800/2023

Editorial

AKI-HRS, more than a name change for type-1 hepatorenal syndrome

DOI: 10.17235/reed.2023.9677/2023

Editorial

New actors come into play against hepatitis delta

DOI: 10.17235/reed.2022.9050/2022

Letter

Hemoperitoneum due to rupture of intra-abdominal varices

DOI: 10.17235/reed.2022.8937/2022

Letter

Pneumatosis intestinalis in a pediatric patient

DOI: 10.17235/reed.2021.8482/2021

Letter

Cirrhotic pattern in advanced hepatic sarcoidosis

DOI: 10.17235/reed.2021.8446/2021

Digestive Diseases Image

Giant cystic hepatocarcinoma in the absence of cirrhosis

DOI: 10.17235/reed.2021.8313/2021

Original

Hepatitis C in homeless people: reaching a hard-to-reach population

DOI: 10.17235/reed.2021.7737/2020

Digestive Diseases Image

Endoscopic forceps removal for complicated magnetic beads impaction

DOI: 10.17235/reed.2021.7731/2020

Review

Physical frailty in liver transplantation

DOI: 10.17235/reed.2020.7448/2020

Review

Risk stratification and treatment of primary biliary cholangitis

DOI: 10.17235/reed.2018.5662/2018

Letter to the Editor

An unusual etiology of abdominal pain in children

DOI: 10.17235/reed.2016.4168/2015

Citation tools
Quintero García D, Sebastián Cuevas F, Crehuá Gaudiza E. Hepatitis C and beta-thalassemia major in children: experience with glecaprevir/pibrentasvir. 7092/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1100 visits.
This article has been downloaded 106 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 31/03/2020

Accepted: 12/04/2020

Online First: 19/11/2020

Published: 08/02/2021

Article revision time: 7 days

Article Online First time: 233 days

Article editing time: 314 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology